Nykode Therapeutics AS (OSL: NYKD)
Norway
· Delayed Price · Currency is NOK 2.974
-0.046 (-1.52%)
Dec 27, 2024, 4:25 PM CET
Nykode Therapeutics AS Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | -37.4 | -35.15 | -42.74 | -9.41 | 149.77 | -13.7 | Upgrade
|
| Depreciation & Amortization | 2.27 | 2.12 | 1.81 | 0.73 | 0.3 | 0.16 | Upgrade
|
| Stock-Based Compensation | 4.92 | 3.7 | 3.83 | 3.44 | 2.6 | 0.89 | Upgrade
|
| Other Operating Activities | -21.36 | -22.41 | -9.5 | -1.62 | 32.96 | -0.62 | Upgrade
|
| Change in Accounts Receivable | -28.91 | -26.59 | 22.43 | -7.17 | -19.46 | -0.37 | Upgrade
|
| Change in Accounts Payable | -1.21 | -2.77 | 2.28 | -0.66 | 6.85 | 1.13 | Upgrade
|
| Change in Unearned Revenue | -5.07 | -15.5 | 6.09 | 17.78 | 1.8 | - | Upgrade
|
| Change in Other Net Operating Assets | -0 | -0.03 | -4.89 | -1.94 | 5.46 | 2.01 | Upgrade
|
| Operating Cash Flow | -86.77 | -96.62 | -20.69 | 1.16 | 180.27 | -10.49 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -99.36% | - | - | Upgrade
|
| Capital Expenditures | -0.19 | -1.9 | -2.68 | -0.87 | -0.1 | -0.08 | Upgrade
|
| Investment in Securities | - | - | 10.04 | 11.35 | -5.93 | -9.02 | Upgrade
|
| Other Investing Activities | 8.26 | 8.94 | 3.68 | 0.27 | 0.01 | 0.04 | Upgrade
|
| Investing Cash Flow | 8.07 | 7.04 | 11.05 | 10.75 | -6.02 | -9.06 | Upgrade
|
| Long-Term Debt Repaid | - | -0.89 | -1.2 | -0.61 | -0.24 | -0.15 | Upgrade
|
| Net Debt Issued (Repaid) | -1 | -0.89 | -1.2 | -0.61 | -0.24 | -0.15 | Upgrade
|
| Issuance of Common Stock | 44.87 | 45.7 | 1.8 | 21.18 | - | 26.05 | Upgrade
|
| Other Financing Activities | -0.18 | -0.22 | -0.24 | -0.13 | -0.05 | -0.03 | Upgrade
|
| Financing Cash Flow | 43.68 | 44.59 | 0.36 | 20.44 | -0.29 | 25.87 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.5 | 1.21 | -0.56 | 0.03 | -0.27 | 0.11 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | -0 | - | 0 | -0 | Upgrade
|
| Net Cash Flow | -34.51 | -43.78 | -9.85 | 32.38 | 173.69 | 6.43 | Upgrade
|
| Free Cash Flow | -86.96 | -98.53 | -23.37 | 0.28 | 180.17 | -10.57 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -99.84% | - | - | Upgrade
|
| Free Cash Flow Margin | -1989.86% | -739.52% | -258.81% | 0.79% | 83.53% | -748.23% | Upgrade
|
| Free Cash Flow Per Share | -0.30 | -0.33 | -0.08 | 0.00 | 0.61 | -0.04 | Upgrade
|
| Cash Interest Paid | 0.19 | 0.22 | 0.24 | 0.13 | 0.05 | 0.03 | Upgrade
|
| Levered Free Cash Flow | -38.36 | -49.62 | -8.6 | 6.38 | 103.92 | -5.28 | Upgrade
|
| Unlevered Free Cash Flow | -38.23 | -49.48 | -8.45 | 6.46 | 103.95 | -5.26 | Upgrade
|
| Change in Net Working Capital | 7.23 | 16.27 | -29.79 | -9.89 | 10.27 | -2.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.